Skip to content
Open access

Inflammasomes and Their Role in Infectious and Autoimmune Diseases

Sep 2026 · Journal of Pharma and Biomedics · 0 citations

TL;DR

The structure, activation, and functions of such important sensors as NLRP1, NLRP3, AIM2, and pyrin are described and their involvement in pathogenesis of diseases as rheumatoid arthritis, type 1 diabetes, atherosclerosis, COVID-19, toxoplasmosis, and malaria is discussed.

Abstract

Inflammasomes are complex molecular formations located in cells and take incharge of regulating the body's immune defence against infectious agents and injury. The initiation of inflammasomes is followed by caspase-1 turning on and gasdermin D being cut, thereby starting a process called pyroptosis. The activation of this process is effective in killing the pathogens, however, prolonged activation of inflammasomes can end up causing long-term inflammation, destruction of tissues, and emergence of different disorders. Herein, the article describes the structure, activation, and functions of such important sensors as NLRP1, NLRP3, AIM2, and pyrin and discusses their involvement in pathogenesis of diseases as rheumatoid arthritis, type 1 diabetes, atherosclerosis, COVID-19, toxoplasmosis, and malaria. As it has been discovered, signalling of Inflammasomes can be either helpful or harmful, and depend on the sensor used, the cellular environment, the agent of infection, as well as the level and length of activation of the signalling pathway. NLRP3 is mainly responsible for non-infectious inflammation, while AIM2 and NLRP1 can be responsible for protection and inflammatory processes. Pyrin is sensitive to the changes in RhoA signalling changes related to viruses, while mutations of disease-causing MEFV gene could lead to the non-regulated activation. Therapeutic approaches directed towards interleukin-1 signalling, NLRP3 formation, functioning of caspase-1, and pyroptosis are effective, despite the fact that they suffer from poor specificity, species difference involved, and lack of clinical application. A detailed knowledge of the regulation of inflammasome and disease-specific signalling may lead to the creation of selective biomarkers.

Read PDF

Similar papers

of Pharma and Biomedics

Mahnoor Ijaz, Soban Arif, F. Tariq et al. · 0 citations
Review Open access Oct 2026

Inflammasomes in respiratory diseases: from disease pathogenesis to drug development and use of multi-omics

Inflammasomes are pivotal for the initiation and control of host inflammatory responses. This is particularly important in the respiratory system due to its direct exposure to noxious environmental and infectious stimuli, which can cause local inflammation, tissue damage and impaired function. Inflammasomes are activat...

R. Shipley, Matthew O'Rourke, Sobia Idrees et al. · 0 citations
Review Open access Oct 2026

NLRP3 Inflammasome in Psoriasis: Role in Disease Pathogenesis, Biomarker Potentiality and Therapeutic Targeting

From an immunological perspective, the term NLRP3 is widely regarded as a critical regulator of immune system dysregulation. The NLRP3 Inflammasome, is basically a complex unit made up of multiple proteins and plays an essential role towards controlling inflammatory signals and the innate immune system. Specifically, p...

S. Panigrahi, A. Aryan, Aarfeen Hussain et al. · 0 citations
Review Open access Sep 2026

The NLRP3 inflammasome in physiological and dysfunctional host response in human sepsis and critical illness: a narrative review

Although targeted modulation of inflammasome pathways represents a promising therapeutic strategy, further research is needed to refine patient selection, identify reliable biomarkers, and better characterise disease heterogeneity to enable successful clinical translation.

Caroline Neumann, Florian Hickl, Julia Kemnitzer et al. · 1 citation · ⚡1
Sep 2026

NNV mediates the activation of the NLRP3 inflammasome through mtDNA release and oxidative DNA damage.

The NLRP3 inflammasome is a cytoplasmic multiprotein complex that is activated under stress or infection conditions. It promotes the maturation of IL-1β by cleaving pro-Caspase-1, thereby playing a critical role in host innate immune responses. Various viruses can differentially activate NLRP3 through distinct mechanis...

Li-Fang Cao, Run-Bin Huang, Lu Yang et al. · 0 citations
Review Oct 2026

NLRP3 inflammasome dysregulation in chronic bacterial infections: mechanistic insights into treatment failure and relapse.

Chronic and recurrent bacterial infections are a significant clinical issue despite the development of antimicrobial treatment. It is increasingly being shown that chronic host-based inflammatory dysregulation is also an integral cause of treatment failure and persistence of illness, and not just the consequence of mic...

J. Girdhar, Sarita Jangra, Apoorv Rastogi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.